Dr Batra’s, a multispecialty chain of homeopathy clinics, is bracing for an entry into hair dyes and colours as part of its recent decision to diversify into flourishing segments that will complement growth in its bead-and-butter hair-treatment and skincare treatment business.
However, pharma companies mainly into formulations have managed to show strong growth, except for those who had operations in Germany and suffered losses due to regulatory changes for drug procurement.
Dishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics.
It is not tough to get a Gujarati thali in Antwerp, and Navratri is a known festival in the Belgian city. Back home in Gujarat, Dinesh Navadia, a diamond trader, is as comfortable with Antwerp as he is with his hometown Surat.
World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.
The race among Indian pharma companies engaged in swine flu vaccine development may soon throw up a winner just when the pandemic enters a critical stage with the onset of winter.
While Gujarat’s chief minister Narendra Modi is down with Swine Flu, the state will see a swine flu vaccine being developed using the most advanced technology available so far.
Lupin Ltd. continues its buying spree with planned acquisitions in Gulf, Mexico, Brazil and Argentina.
In what is seen as a boost to the stem cell research in the country, India would soon get to host human clinical trials for therapies using umbilical blood cord stem cell.
The Gujarat High Court upholds contention that trademark was derived from ingredient and was in use for long.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon